MELBOURNE, April 29 AAP - Biotech BresaGen Ltd's US affiliate Cellsaurus Inc has received a grant from the National Institutes of Health in the US for human embryonic stem cell research.
BresaGen said the award, which will be shared with three other non-listed organisations, provides approximately $US3.5 million over two years.
BresaGen president and chief executive officer Dr John Smeaton said the research award complemented the product development activities of the company, which had been recognised by both the Australian and American governments.
AAP tsc
BGN Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held
